🇺🇸 FDA
Patent

US 11867695

Compositions and methods for detecting protease activity in biological systems

granted A61KA61K47/6849A61K47/6855

Quick answer

US patent 11867695 (Compositions and methods for detecting protease activity in biological systems) held by CytomX Therapeutics, Inc. expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CytomX Therapeutics, Inc.
Grant date
Tue Jan 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K47/6849, A61K47/6855, A61K47/6889, A61K49/0021